Cargando…
Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection
Interkingdom polymicrobial diseases are caused by different microorganisms that colonize the same niche, as in the case of yeast-bacteria coinfections. The latter are difficult to treat due the absence of any common therapeutic target for their elimination, both in animals and humans. Staphylococcus...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560154/ https://www.ncbi.nlm.nih.gov/pubmed/32842593 http://dx.doi.org/10.3390/antibiotics9090530 |
_version_ | 1783595023880683520 |
---|---|
author | Bellavita, Rosa Vollaro, Adriana Catania, Maria Rosaria Merlino, Francesco De Martino, Luisa Nocera, Francesca Paola DellaGreca, Marina Lembo, Francesca Grieco, Paolo Buommino, Elisabetta |
author_facet | Bellavita, Rosa Vollaro, Adriana Catania, Maria Rosaria Merlino, Francesco De Martino, Luisa Nocera, Francesca Paola DellaGreca, Marina Lembo, Francesca Grieco, Paolo Buommino, Elisabetta |
author_sort | Bellavita, Rosa |
collection | PubMed |
description | Interkingdom polymicrobial diseases are caused by different microorganisms that colonize the same niche, as in the case of yeast-bacteria coinfections. The latter are difficult to treat due the absence of any common therapeutic target for their elimination, both in animals and humans. Staphylococcus pseudintermedius and Malassezia pachydermatis belong to distinct kingdoms. They can colonize the same skin district or apparatus being the causative agents of fastidious pet animals’ pathologies. Here we analysed the antimicrobial properties of a panel of 11 peptides, derived from temporin L, against Malassezia pachydermatis. Only peptide 8 showed the best mycocidal activity at 6.25 μM. Prolonged application of peptide 8 did not cause M. pachydermatis drug-resistance. Peptide 8 was also able to inhibit the growth of Staphylococcus pseudintermedius, regardless of methicillin resistance, at 1.56 μM for methicillin-susceptible S. pseudintermedius (MSSP) and 6.25 μM for methicillin-resistant S. pseudintermedius (MRSP). Of interest, peptide 8 increased the susceptibility of MRSP to oxacillin. Oxacillin MIC value reduction was of about eight times when used in combination with peptide 8. Finally, the compound affected the vitality of bacteria embedded in S. pseudintermedius biofilm. In conclusion, peptide 8 might represent a valid therapeutic alternative in the treatment of interkingdom polymicrobial infections, also in the presence of methicillin-resistant bacteria. |
format | Online Article Text |
id | pubmed-7560154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75601542020-10-22 Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection Bellavita, Rosa Vollaro, Adriana Catania, Maria Rosaria Merlino, Francesco De Martino, Luisa Nocera, Francesca Paola DellaGreca, Marina Lembo, Francesca Grieco, Paolo Buommino, Elisabetta Antibiotics (Basel) Article Interkingdom polymicrobial diseases are caused by different microorganisms that colonize the same niche, as in the case of yeast-bacteria coinfections. The latter are difficult to treat due the absence of any common therapeutic target for their elimination, both in animals and humans. Staphylococcus pseudintermedius and Malassezia pachydermatis belong to distinct kingdoms. They can colonize the same skin district or apparatus being the causative agents of fastidious pet animals’ pathologies. Here we analysed the antimicrobial properties of a panel of 11 peptides, derived from temporin L, against Malassezia pachydermatis. Only peptide 8 showed the best mycocidal activity at 6.25 μM. Prolonged application of peptide 8 did not cause M. pachydermatis drug-resistance. Peptide 8 was also able to inhibit the growth of Staphylococcus pseudintermedius, regardless of methicillin resistance, at 1.56 μM for methicillin-susceptible S. pseudintermedius (MSSP) and 6.25 μM for methicillin-resistant S. pseudintermedius (MRSP). Of interest, peptide 8 increased the susceptibility of MRSP to oxacillin. Oxacillin MIC value reduction was of about eight times when used in combination with peptide 8. Finally, the compound affected the vitality of bacteria embedded in S. pseudintermedius biofilm. In conclusion, peptide 8 might represent a valid therapeutic alternative in the treatment of interkingdom polymicrobial infections, also in the presence of methicillin-resistant bacteria. MDPI 2020-08-22 /pmc/articles/PMC7560154/ /pubmed/32842593 http://dx.doi.org/10.3390/antibiotics9090530 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bellavita, Rosa Vollaro, Adriana Catania, Maria Rosaria Merlino, Francesco De Martino, Luisa Nocera, Francesca Paola DellaGreca, Marina Lembo, Francesca Grieco, Paolo Buommino, Elisabetta Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection |
title | Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection |
title_full | Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection |
title_fullStr | Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection |
title_full_unstemmed | Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection |
title_short | Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection |
title_sort | novel antimicrobial peptide from temporin l in the treatment of staphylococcus pseudintermedius and malassezia pachydermatis in polymicrobial inter-kingdom infection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560154/ https://www.ncbi.nlm.nih.gov/pubmed/32842593 http://dx.doi.org/10.3390/antibiotics9090530 |
work_keys_str_mv | AT bellavitarosa novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection AT vollaroadriana novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection AT cataniamariarosaria novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection AT merlinofrancesco novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection AT demartinoluisa novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection AT nocerafrancescapaola novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection AT dellagrecamarina novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection AT lembofrancesca novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection AT griecopaolo novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection AT buomminoelisabetta novelantimicrobialpeptidefromtemporinlinthetreatmentofstaphylococcuspseudintermediusandmalasseziapachydermatisinpolymicrobialinterkingdominfection |